.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Thomas Burkhardt

Plauen / DE

DRK-Blutspendedienst Nord-Ost gGmbH

Referent

13/09/2024
14:00 – 14:20 15 Min. 5 Min.
Lecture
Update Donorvigilanz Thombozytapherese/Plasmapherese

Further involvements

11/09/2024
Poster
P-15-11
Donor vigilance – Severe adverse events of whole blood donation
Donorvigilanz – Schwerwiegende Nebenwirkungen der Vollblutspende
Late breaking abstract
13/09/2024
09:30 – 09:45 12 Min. 3 Min.
Abstract lecture
FV-50
SARS-CoV-2 convalescent plasma for the controlled clinical trial "COVIC-19": Experience from collection of very high-titer plasma from superimmunized individuals
SARS-CoV-2 Rekonvaleszentenplasma für die klinische Studie "COVIC-19": Erfahrungen mit der Sammlung von sehr hochtitrigem Plasma von superimmunisierten Personen
Blood Donation